Showing 611-620 of 3302 results for "".
How does chronic AD histopathology evolve from spongiosis-dominant lesions to lichenified, fibrotic plaques?
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/how-does-chronic-ad-histopathology-evolve-from-spongiosis-dominant-lesions-to-lichenified-fibrotic-plaques/48772/Christopher Bunick, MD, FAAD, discusses the roles of the six major cytokines that drive atopic dermatitis pathophysiology: IL-4, IL-13, IL-31, TSLP, IL-22, and IFN-γ.Expanding Access to Care Through a Virtual Platform
https://practicaldermatology.com/videos/c-suite-chats/expanding-access-to-care-through-a-virtual-platform/69071/Patrick Burnett, MD, PhD, FAAD, Chief Medical Officer for Arcutis, discusses a new virtual health platform designed to expand access pathways to roflumilast for chronic inflammatory skin diseases.What’s New in Nonmelanoma Skin Cancers
https://practicaldermatology.com/conferences/science-of-skin-summit-2025/tbd/39735/Todd Schlesinger, MD, FAAD, talks about recent advances in diagnosis, therapy, and prevention of nonmelanoma skin cancers. This video was recorded at the Science of Skin Summit in Austin, TX.What’s New in Psoriasis
https://practicaldermatology.com/conferences/science-of-skin-summit-2025/tbd/39743/Chris Bunick, MD, FAAD, talks about new therapeutic directions, real‑world data, and challenges in psoriasis management. This video was recorded at the Science of Skin Summit in Austin, TX.DermWireTV: ASDS Meeting Highlights; Daxxify Data; PA Week
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-asds-meeting-highlights-daxxify-data-pa-week/20147/ASDS speakers address aesthetic advancements, skin cancer, and DEI with Joel L. Cohen, MD, Sherrif Ibrahim, MD, and Jeanine Downie, MD. On the heels of FDA approval of Revance’s Daxxify, data published in the Aesthetic Surgery Journal demonstrate the efficacy of DaxibotulinumtoxinA fRF Technologies: What should you know?
https://practicaldermatology.com/videos/scientifically-speaking/rf-technologies-what-should-you-know/19848/With so many radiofrequency devices now on the market and new ones in development, aesthetic specialists need to know how to select the proper tool for each patient need. E. Victor Ross, MD and Erez Dayan, MD join host Joel L. Cohen, MD to go beyond the marketing jargon to assess the science and cliTransitioning From Academia to Private Practice
https://practicaldermatology.com/issues/august-2025/transitioning-from-academia-to-private-practice/36705/YoungMD Connect recently hosted an “Ask Me Anything” mentorship session with Tina Bhutani, MD, MAS, FAAD, during which she discussed her shift in career trajectory from academia to private practice and the insights she gained along the way.Updates from ASDS and ISHRS
https://practicaldermatology.com/videos/dermwire-tv/-dermwiretv-updates-from-asds-and-ishrs/18217/The Annual meeting of the American Society for Dermatologic Surgery (ASDS) gathered experts in dermatologic surgery in Phoenix. Joel L. Cohen, MD and Shannon Humphrey, MD, who received the 2018 ASDS Award for Outstanding Service, discussed effective cosmetic consults. Diane Berson, MD addressed bothDermWireTV: Candela + Merz Aesthetics Partnership, COVID-19 Vaccines & Fillers, Almirall's Klisyri, MetSyn & PsO
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-candela-merz-aesthetics-partnership-covid-19-vaccines-and-fillers-almiralls-klisyri-metsyn-and-pso/19893/Klisyri® (tirbanibulin) ointment 1% from Almirall will be available for treatment of AKs by the end of this quarter; Ayman Grada, MD discusses. Are patients who have received dermal filler injections at risk for developing reactions to the COVID-19 vaccine? Joel L. Cohen, MD and Doris Day, MD weighUsing the REVIAN Red System for Your Hair Loss Patients
https://practicaldermatology.com/topics/hair-nails/using-the-revian-red-system-for-your-hair-loss-patients/19754/Hear a few practical insights from hair loss experts Suneel Chilukuri, MD, Joel Cohen, MD and Michael Gold, MD about how they incorporate the new REVIAN Red dual-band LED wireless cap and smart app in their practices! REVIAN Red is indicated to treat androgenetic alopecia and to promote hair growth